Letter to the Editor

Maculopapular Cutaneous Mastocytosis Successfully Treated with Omalizumab

Eleftheria Tampouratzi ; Department of Dermatology and Venereology, Tzaneio General Hospital, Piraeus, Greece
Theodora Kanni ; Department of Dermatology and Venereology, Andreas Sygros Hospital, Athens, Greece
John Katsantonis ; Department of Dermatology and Venereology, Tzaneio General Hospital, Piraeus, Greece
Theodora Douvali ; Department of Dermatology and Venereology, Andreas Sygros Hospital, Athens, Greece

Abstract

Maculopapular cutaneous mastocytosis (MPCM),
formerly telangiectasia macularis eruptiva perstans
(TMEP), is an uncommon form of cutaneous mastocytosis
first described on 1930 (1). It is more frequent
in adults, and early diagnosis is crucial since it has
been reported to be associated with serious underlying
systemic disorders, such as myeloproliferative
diseases and severe manifestations like anaphylaxis
(2,3). Treatment of MPCM depends on the presence of
systemic involvement and/or the clinical symptoms
of the disease itself

Keywords

Hrčak ID:

274450

URI

https://hrcak.srce.hr/274450

Publication date:

17.3.2021.

Visits: 854 *